SOLENO THERAPEUTICS INC（SLNO）内部人交易：高管与董事近期交易
过去 18 个月，共有 15 位内部人为 SOLENO THERAPEUTICS INC（SLNO）报告了 46 笔 Form 4 交易（最近一笔 2026-05-18）。
| 日期 | 内部人 | 职务 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-05-18 | Huang Michael F. | Sr. VP of Clinical Development | 卖出 | 39,823 | $0 |
| 2026-05-18 | Volck Birgitte | 董事 | 卖出 | 17,536 | $0 |
| 2026-05-18 | Yen Kristen | Officer title: SVP Global Clinical Operations and Patient Advocacy | 卖出 | 37,639 | $0 |
| 2026-05-18 | Sinclair Andrew | 董事 | 卖出 | 10,491 | $0 |
| 2026-05-18 | Norrett Kevin | Chief Business Officer | 卖出 | 17,786 | $0 |
| 2026-05-18 | Hahn Mark W | 董事 | 卖出 | 10,046 | $0 |
| 2026-05-18 | Joshi Manher | Chief Development Officer | 卖出 | 20,171 | $0 |
| 2026-05-18 | Fulk Jennifer | CHIEF FINANCIAL OFFICER | 卖出 | 39,200 | $0 |
| 2026-05-18 | Pauls Matthew | 董事 | 卖出 | 10,491 | $0 |
| 2026-05-18 | Anish Bhatnagar | CHIEF EXECUTIVE OFFICER | 卖出 | 583,656 | $0 |
| 2026-05-18 | Hirano Patricia C | Officer title: Senior Vice President, Regulatory Affairs | 卖出 | 22,702 | $0 |
| 2026-05-18 | Manning Meredith | Chief Commercial Officer | 卖出 | 64,507 | $0 |
| 2026-05-18 | Bir Dawn Carter | 董事 | 卖出 | 16,991 | $0 |
| 2026-03-31 | Huang Michael F. | Sr. VP of Clinical Development | 卖出 | 4,256 | $127,850 |
| 2026-03-31 | Huang Michael F. | Sr. VP of Clinical Development | 卖出 | 1,838 | $57,052 |
| 2026-03-31 | Huang Michael F. | Sr. VP of Clinical Development | 卖出 | 488 | $15,479 |
| 2026-03-31 | Manning Meredith | Chief Commercial Officer | 卖出 | 4,864 | $146,115 |
| 2026-03-31 | Manning Meredith | Chief Commercial Officer | 卖出 | 2,100 | $65,184 |
| 2026-03-31 | Manning Meredith | Chief Commercial Officer | 卖出 | 558 | $17,700 |
| 2026-03-04 | Fulk Jennifer | CHIEF FINANCIAL OFFICER | 买入 | 39,200 | $0 |
| 2026-01-23 | Huang Michael F. | Sr. VP of Clinical Development | 买入 | 10,400 | $0 |
| 2026-01-23 | Joshi Manher | Chief Development Officer | 买入 | 4,100 | $0 |
| 2026-01-23 | Mackaness James H | CHIEF FINANCIAL OFFICER | 买入 | 28,600 | $0 |
| 2026-01-23 | Hirano Patricia C | Officer title: Senior Vice President, Regulatory Affairs | 买入 | 10,400 | $0 |
| 2026-01-23 | Anish Bhatnagar | CHIEF EXECUTIVE OFFICER | 买入 | 114,200 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-05-18